It sells an experimental weight-loss jab, retatrutide, that has not yet completed clinical trials
A recombinant human glucagon-like peptide (GLP)-1albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
But beneath the hype and fear is a simple story: these drugs target a core metabolic signaling pathway that influences cardiovascular health, inflammation, cognition, kidney function, and long-term resilience
These therapeutic errors may lead to an increase in calls to poison control centers and emergency department visits related to medication errors nationwide
Research is ongoing, but it's a promising area, possibly because these drugs affect the brain's reward system in a similar way they affect food cravings
In contrast, semaglutide, liraglutide, and dulaglutide undergo proteolytic degradation with minimal renal clearance, making them suitable options for patients with renal impairment, though caution is still advised